Hypoglycemia enhances the expression of mRNA encoding β-amyloid precursor protein in rat primary cortical astroglial cells

Brain Research

Volumn 772, Issue 1-2, 1997, Pages 247-251

  Shi, Jiong ^a   Xiang, Ying ^b   Simpkins, James W ^a  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

^b Department of Pharmacodynamics   (United States)

Author keywords

Amyloid mRNA; Glucose deprivation; Kunitz type protease inhibitor domain; RT PCR

Indexed keywords

ADENOSINE TRIPHOSPHATE; AMYLOID PRECURSOR PROTEIN; GLUCOSE; MESSENGER RNA; SERINE PROTEINASE INHIBITOR;

ALTERNATIVE RNA SPLICING; ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; ASTROCYTE; BRAIN CORTEX; CELL VIABILITY; CONTROLLED STUDY; GENE EXPRESSION; GLUCOSE METABOLISM; HYPOGLYCEMIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; ASTROCYTES; CELLS, CULTURED; CEREBRAL CORTEX; GENETIC CODE; HYPOGLYCEMIA; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER;

EID: 0030727701     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)00827-5     Document Type: Article

References (11)

1. Checler F. Processing of the β-Amyloid precursor protein and its regulation in Alzheimer's disease. J. Neurochem. 65:1995;1431-1444.
2. Davis R.E., Miller S., Herrnstadt C., Ghosh S.S., Fahy E., Shinobu L.A., Galasko D., Thal L.J., Beal M.F., Howell N., Parker W.D. Jr. Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer disease. Proc. Natl. Acad. Sci. USA. 94:1997;4526-4531.
3. Friedland R.P., Jagust W.J., Huesman R.H., Koss E., Knittel B., Mathis C.A., Ober B.A., Mazoyer B.M., Budinger T.F. Regional cerebral glucose transport and utilization in Alzheimer's disease. Neurology. 39:1989;1427-1434.
4. Green P.S., Gridley K.E., Simpkins J.W. Estradiol protects against β-amyloid (25-35)-induced toxicity in SK-N-SH human neuroblastoma cells. Neurosci. Lett. 218:1996;165-168.
5. Johnson S.A., McNeill T., Cordell B., Finch C.E. Relation of Neurol App-751/App-695 mRNA ratio and neuritic plaque density in Alzheimer's disease. Science. 248:1990;854-857.
6. Kennedy A.M., Frackowiak R.S.J., Newman S.K., Bloomfield P.M., Seaward J., Roques P., Lewington G., Cunningham V.J. Deficits in cerebral glucose metabolism demonstrated by positron emission tomography in individuals at risk of familial Alzheimer's disease. Neurosci. Lett. 186:1995;17-20.
7. 2+ homeostasis in Alzheimer's disease. Trends Neurosci. 16:1993;409-414.
8. Naidu A., Quon D., Cordell B. β -Amyloid peptide produced in vitro is degraded by proteinases released by cultured cells. J. Biol. Chem. 270(3):1995;1369-1374.
9. J. Shi, Y.Q. Zhang, J.W. Simpkins, Effects of 17 β-estradiol on glucose transporter 1 expression and endothelial cell survival following focal ischemia in the rats, Exp. Brain Res. 1997, in press.
10. Sumners C., Tang W., Zelezna B., Raizada M.K. Angiotensin II receptor subtypes are coupled with distinct signal transduction mechanisms in neurons and astroglia. Proc. Natl. Acad. Sci. USA. 88:1991;7567-7571.
11. Zelezna B., Rydzewski B., Lu D., Olson J.A., Shiverick K.T., Tang W., Summers C., Raizada M.K. Angiotensin II induction of plasminogen activator-inhibitor-1 gene expression in astroglial cells of normotensive and spontaneously hypertensive rat brain. Mol. Endocrinol. 6:1992;2009-2017.